FEV 1 showed an increasing trend after 1 year of treatment with LI and remained stable after 3 years of treatment.
← all excerpts
One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes.
1
—
—